Assertio Holdings Inc (ASRT)
1.015
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
1.015
0.00 (0.00%)
After-Hours: 20:00
Assertio Holdings Cash from Operations (Quarterly): 7.508M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.508M |
| December 31, 2023 | 5.707M |
| September 30, 2023 | 2.579M |
| June 30, 2023 | 18.60M |
| March 31, 2023 | 22.72M |
| December 31, 2022 | 26.70M |
| September 30, 2022 | 10.04M |
| June 30, 2022 | 14.43M |
| March 31, 2022 | 27.43M |
| December 31, 2021 | 4.131M |
| September 30, 2021 | 4.654M |
| June 30, 2021 | 0.964M |
| March 31, 2021 | -4.226M |
| December 31, 2020 | -5.982M |
| September 30, 2020 | -14.43M |
| June 30, 2020 | -20.10M |
| March 31, 2020 | -25.06M |
| December 31, 2019 | 7.855M |
| September 30, 2019 | 33.91M |
| June 30, 2019 | 21.51M |
| March 31, 2019 | 27.20M |
| December 31, 2018 | 15.76M |
| September 30, 2018 | 70.77M |
| June 30, 2018 | 12.94M |
| March 31, 2018 | -26.98M |
| Date | Value |
|---|---|
| December 31, 2017 | 27.26M |
| September 30, 2017 | -3.206M |
| June 30, 2017 | 22.10M |
| March 31, 2017 | 16.01M |
| December 31, 2016 | 41.04M |
| September 30, 2016 | 17.29M |
| June 30, 2016 | 29.02M |
| March 31, 2016 | -16.08M |
| December 31, 2015 | 66.53M |
| September 30, 2015 | 48.76M |
| June 30, 2015 | 39.57M |
| March 31, 2015 | -2.493M |
| December 31, 2014 | 3.166M |
| September 30, 2014 | -0.692M |
| June 30, 2014 | 6.928M |
| March 31, 2014 | -65.32M |
| December 31, 2013 | -0.668M |
| September 30, 2013 | 14.13M |
| June 30, 2013 | 1.164M |
| March 31, 2013 | -4.868M |
| December 31, 2012 | -5.718M |
| September 30, 2012 | -0.402M |
| June 30, 2012 | -13.35M |
| March 31, 2012 | -11.52M |
| December 31, 2011 | -14.73M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-25.06M
Minimum
Mar 2020
33.91M
Maximum
Sep 2019
6.947M
Average
6.608M
Median
Cash from Operations (Quarterly) Benchmarks
| Ocular Therapeutix Inc | -33.89M |
| Vertex Pharmaceuticals Inc | 1.307B |
| Cormedix Inc | -17.31M |
| Verastem Inc | -28.31M |
| CytomX Therapeutics Inc | -26.04M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.206M |
| Free Cash Flow | 34.40M |
| Free Cash Flow Per Share (Quarterly) | 0.079 |
| Free Cash Flow to Equity (Quarterly) | 7.401M |
| Free Cash Flow to Firm (Quarterly) | 8.288M |
| Free Cash Flow Yield | 39.66% |